Trials / Terminated
TerminatedNCT03311295
MitrAl ValvE RepaIr Clinical Trial (MAVERIC Trial) - United States
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Mvrx, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to evaluate the safety and feasibility of the ARTO System in patients with mitral valve regurgitation (MR) associated with congestive heart failure (CHF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ARTO System | The ARTO System directly reshapes the mitral annulus promoting leaflet coaptation and amelioration of regurgitation. |
Timeline
- Start date
- 2018-04-03
- Primary completion
- 2021-04-26
- Completion
- 2021-04-26
- First posted
- 2017-10-17
- Last updated
- 2021-04-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03311295. Inclusion in this directory is not an endorsement.